蒋思怡;宋小英;张丹丹;李正磊;杨玉莹;罗心遥;叶晓川;
JIANG Si-yi;SONG Xiao-ying;ZHANG Dan-dan;LI Zheng-lei;YANG Yu-ying;LUO Xin-yao;YE Xiao-chuan;Key Laboratory of Traditional Chinese Medicine Resources and Chemistry of Traditional Chinese Medicine in Hubei Province,College of Pharmacy,Hubei University of Traditional Chinese Medicine;

• 1:湖北中医药大学药学院中药资源与中药化学湖北省重点实验室

摘要(Abstract)：

研究菝葜UPLC指纹图谱与其抗盆腔炎作用的相关性,探究菝葜抗盆腔炎的药效物质基础。建立10批不同产地菝葜UPLC指纹图谱,测定盆腔炎模型大鼠的SOD,MDA,TNF-α,IL-6,采用层次分析法确定各单一指标对总药效的权重,运用灰色关联度法分析菝葜指纹图谱中各峰对各单一药效指标及总药效的贡献,并通过与对照品比对指认色谱峰化学成分结构。10批菝葜UPLC指纹图谱27个共有特征峰均是与菝葜抗盆腔炎症作用相关色谱峰,其中13个色谱峰被指认,分别为2号峰(3,5-二羟基-2-甲基苯甲酸-3-O-葡萄糖苷),3号峰(绿原酸),5号峰(2,7,4'-三羟基黄酮-5-O-葡萄糖苷),6号峰(二氢山柰酚-5-O-葡萄糖苷),7号峰(二氢山柰酚-7-O-葡萄糖苷),9号峰(花旗松素),10号峰(白藜芦醇苷),11号峰(氧化白藜芦醇),12号峰(落新妇苷),15号峰(白藜芦醇),16号峰(槲皮苷),18号峰(黄杞苷)以及24号峰(山柰酚);有21个色谱峰与总药效的关联度大于0. 8,按关联度排名前10的顺序为1,3,7,19,18,17,4,11,16,21号峰。研究结果显示,菝葜抗盆腔炎为药效物质群共同作用的结果;为了更有效控制菝葜药材及饮片质量,应合理选择含量检测的指标性成分。
To study the correlation between ultra high performance liquid chromatography( UPLC) fingerprint of Smilax china and its anti-pelvic inflammatory effect,and to explore the pharmacodynamic material basis of S. china against pelvic inflammatory disease.UPLC fingerprints of 10 batches of S. china from different habitats were established,and the values of SOD,MDA,TNF-α,and IL-6 in rats with pelvic inflammation were measured. The weight of each single pharmacodynamics index to the total efficacy was determined by analytic hierarchy process,and the contribution of each peak in fingerprints to the each single pharmacodynamics index and total efficacy was analyzed by the grey relational analysis. Then the structures of chemical constituents at the identified peaks were confirmed by comparing with the reference substance. The 27 common characteristic peaks of UPLC fingerprints were all related to the anti-pelvic inflammation effect of S. china,of which 13 peaks were identified as peak 2( 3,5-dihydroxy-2-methylbenzoic acid-3-O-glucoside),peak 3( chlorogenic acid),peak 5( 2,7,4-trihydroxydihydroflavone-5-O-glucoside),peak 6( 7,4-dihydroxydihydroflavonol-5-O-glucoside),peak 7( taxifolin-7-O-glucoside),peak 9( taxifolin),peak 10( polydatin),peak 11( oxyresveratrol),peak 12( astilbin),peak15( resveratrol),peak 16( quercitrin),peak 18( engeletin) and peak 24( kaempferol). The correlation degree of 21 peaks and the total efficacy was greater than 0. 8,and the top 10 ranked by correlation degree were as follows: peak 1,3,7,19,18,17,4,11,16,and 21. The results showed that the anti-pelvic inflammation effect of S. china was achieved by the combined action of pharmacodynamic substances. In order to control the quality of S. china and its prepared slices more effectively,the index components of content detection should be selected reasonably.

关键词(KeyWords)： 菝葜;盆腔炎;指纹图谱;谱效关系;灰色关联度;层次分析
Smilax china;anti-inflammation;fingerprint;spectrum-effect relationship;grey relational analysis;analytic hierarchy process

Abstract:

Keywords:

基金项目(Foundation): 国家自然科学基金项目(31370378)

作者(Author): 蒋思怡;宋小英;张丹丹;李正磊;杨玉莹;罗心遥;叶晓川;
JIANG Si-yi;SONG Xiao-ying;ZHANG Dan-dan;LI Zheng-lei;YANG Yu-ying;LUO Xin-yao;YE Xiao-chuan;Key Laboratory of Traditional Chinese Medicine Resources and Chemistry of Traditional Chinese Medicine in Hubei Province,College of Pharmacy,Hubei University of Traditional Chinese Medicine;

Email:

DOI:

参考文献(References)：

• [1]中国药典.一部[S]. 2015:309.
• [2]杨勇,郭智绵.中药菝葜的研究现状与临床应用[J].中医药导报,2012,18(11):89.
• [3] Shao B,Guo H,Cui Y,et al. Steroidal saponins from Smilax china and their anti-inflammatory activities[J]. Phytochemistry,2007,68(5):623.
• [4]晏绿金,文莉,干国平,等.菝葜活性部位抗炎机理研究[J].中药材,2008,32(8):1235.
• [5]王红英,黄燕芬.菝葜抗小鼠移植性肿瘤的实验研究[J].海峡药学,2012,24(9):23.
• [6]罗丹.菝葜抗炎有效部位群的活性成分及其作用机制研究[D].武汉:湖北中医药大学,2016.
• [7]李戎,闫智勇,李文军,等.创建中药谱效理论学[J].中医教育,2002,2(21):62.
• [8]马云,罗艳琴,宋路瑶,等.菝葜各化学部位对大鼠慢性盆腔炎模型的治疗作用[J].第三军医大学学报,2013,35(12):1267.
• [9]段晓颖,辛笑迪,翟海容,等.层次分析法多指标均匀实验优选西洋参醇提工艺[J].中医学报,2018,33(7):1318.
• [10]李慧,刘其南,张丽,等.基于层次分析法及多指标正交试验优选酒炖女贞子炮制工艺[J].中草药,2016,47(16):2832.
• [11]邓雪,李家铭,曾浩健,等.层次分析法权重计算方法分析及其应用研究[J].数学的实践与认识,2012,42(7):93.
• [12]邹纯才,洪国君,鄢海燕.不同数据标准化方法对瓜蒌滴丸抗凝血作用谱效关系的影响[J].中国中药杂志,2018,43(9):1864.
• [13]耿媛媛,胡昌江,潘新,等.二神丸不同提取部位温脾止泻的谱效关系研究[J].中草药,2014,45(18):2658.
• [14]孙莉琼,戚进,余伯阳.多维谱效关系在中药研究中的进展[J].中国药科大学学报,2013,44(6):487.
• [15]廖婉,章津铭,傅舒,等.醋莪术对气滞血瘀证血液流变学影响的表征及谱效相关性研究[J].中成药,2013,35(2):330.
• [16]宋小英,罗丹,叶晓川,等.菝葜抗炎有效部位群的效应成分研究[J].湖北中医药大学学报,2017,19(3):1.